<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03378843</url>
  </required_header>
  <id_info>
    <org_study_id>Bruneck_2017_Spermidine</org_study_id>
    <nct_id>NCT03378843</nct_id>
  </id_info>
  <brief_title>Spermidine Intake and All-cause Mortality</brief_title>
  <official_title>Association Between Dietary Spermidine Intake and Mortality in the Population-based Bruneck Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Krankenhaus Bruneck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Paracelsus Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitaet Innsbruck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to test the potential association between spermidine content in diet and
      mortality in humans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective community-based cohort study includes 829 participants aged 45-84 years,
      49.9% of which are male. Diet is assessed by repeated dietician-administered validated
      food-frequency questionnaires (2540 assessments) in 1995, 2000, 2005, and 2010. Nutrient
      intakes including spermidine are calculated using USDA standard databases. Clinical events
      (all-cause mortality and cause-specific mortality) are recorded from 1995 to 2015.

      The primary endpoint of all-cause mortality is related to the exposure of long-term average
      spermidine intake by Cox proportional hazards models with time-varying covariates. Additional
      analyses employ the Fine and Gray proportional subdistribution hazards model and flexible
      Royston-Parmar spline-based models. Comprehensive sensitivity analyses are performed to guard
      against potential biases associated with nutritional epidemiology.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1995</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>1995-2015</time_frame>
    <description>Death due to any cause</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cause-specific mortalities</measure>
    <time_frame>1995-2015</time_frame>
    <description>Death due to cardiovascular disease, cancer, or other causes</description>
  </secondary_outcome>
  <enrollment type="Actual">829</enrollment>
  <condition>Healthy Diet</condition>
  <condition>Mortality</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spermidine content of natural diet</intervention_name>
    <description>The exposure consists in the long-term average dietary intake of the polyamine spermidine</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A random sample intended to represent the general population, recruited in 1990.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Resident of Bruneck aged 40-79 years in 1990, age- and sex-stratified random sample.

        Exclusion Criteria: None.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Kiechl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Innsbruck</affiliation>
  </overall_official>
  <reference>
    <citation>Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002 Jul 18;347(3):185-92.</citation>
    <PMID>12124407</PMID>
  </reference>
  <reference>
    <citation>Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, Menni C, Moayyeri A, Santer P, Rungger G, Spector TD, Willeit J, Kiechl S, Mayr M. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation. 2014 May 6;129(18):1821-31. doi: 10.1161/CIRCULATIONAHA.113.002500. Epub 2014 Mar 12.</citation>
    <PMID>24622385</PMID>
  </reference>
  <reference>
    <citation>Pechlaner R, Tsimikas S, Yin X, Willeit P, Baig F, Santer P, Oberhollenzer F, Egger G, Witztum JL, Alexander VJ, Willeit J, Kiechl S, Mayr M. Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III. J Am Coll Cardiol. 2017 Feb 21;69(7):789-800. doi: 10.1016/j.jacc.2016.11.065.</citation>
    <PMID>28209220</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2017</study_first_submitted>
  <study_first_submitted_qc>December 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2017</study_first_posted>
  <last_update_submitted>December 14, 2017</last_update_submitted>
  <last_update_submitted_qc>December 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University Innsbruck</investigator_affiliation>
    <investigator_full_name>Stefan Kiechl</investigator_full_name>
    <investigator_title>A.Univ.-Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Polyamine, cardiovascular disease, cancer</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We do not plan to share individual participant data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

